NO952854L - 1-arylpyrimidin-derivater - Google Patents
1-arylpyrimidin-derivaterInfo
- Publication number
- NO952854L NO952854L NO952854A NO952854A NO952854L NO 952854 L NO952854 L NO 952854L NO 952854 A NO952854 A NO 952854A NO 952854 A NO952854 A NO 952854A NO 952854 L NO952854 L NO 952854L
- Authority
- NO
- Norway
- Prior art keywords
- oxo
- together form
- substituted
- methylcyclohexyl
- pyran
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16722294 | 1994-07-19 | ||
| JP19421994 | 1994-08-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952854D0 NO952854D0 (no) | 1995-07-18 |
| NO952854L true NO952854L (no) | 1996-01-22 |
Family
ID=26491330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952854A NO952854L (no) | 1994-07-19 | 1995-07-18 | 1-arylpyrimidin-derivater |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5661153A (de) |
| EP (1) | EP0700908A1 (de) |
| AU (1) | AU681034B2 (de) |
| CA (1) | CA2154293A1 (de) |
| FI (1) | FI953479A7 (de) |
| NO (1) | NO952854L (de) |
| NZ (1) | NZ272591A (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6514949B1 (en) | 1994-07-11 | 2003-02-04 | University Of Virginia Patent Foundation | Method compositions for treating the inflammatory response |
| US6448235B1 (en) | 1994-07-11 | 2002-09-10 | University Of Virginia Patent Foundation | Method for treating restenosis with A2A adenosine receptor agonists |
| US5821247A (en) * | 1996-09-19 | 1998-10-13 | Japan Energy Corporation | Hydroquinone derivative and pharmaceutical use thereof |
| AU6320998A (en) | 1997-02-21 | 1998-09-09 | Bristol-Myers Squibb Company | Benzoic acid derivatives and related compounds as antiarrhythmic agents |
| US6117878A (en) * | 1998-02-24 | 2000-09-12 | University Of Virginia | 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors |
| RU2207337C2 (ru) * | 1998-11-18 | 2003-06-27 | Изаксон Елена Александровна | 6-(3-ацетилфенил)аминоурацил |
| US7427606B2 (en) | 1999-02-01 | 2008-09-23 | University Of Virginia Patent Foundation | Method to reduce inflammatory response in transplanted tissue |
| US7378400B2 (en) | 1999-02-01 | 2008-05-27 | University Of Virginia Patent Foundation | Method to reduce an inflammatory response from arthritis |
| US6232297B1 (en) | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
| US6322771B1 (en) | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
| US6670334B2 (en) | 2001-01-05 | 2003-12-30 | University Of Virginia Patent Foundation | Method and compositions for treating the inflammatory response |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| NZ556354A (en) | 2001-10-01 | 2008-10-31 | Univ Virginia | 2-Propynyl adenosine analogs having A2A agonist activity and compositions thereof |
| EA009701B1 (ru) * | 2002-06-06 | 2008-02-28 | Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. | Противоаллергические средства |
| WO2004026842A1 (ja) * | 2002-09-20 | 2004-04-01 | Sumitomo Pharmaceuticals Co., Ltd. | 新規ウラシル誘導体及びその医薬用途 |
| GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| BRPI0507746A (pt) * | 2004-02-18 | 2007-07-10 | Astrazeneca Ab | composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto |
| KR20070007104A (ko) * | 2004-02-18 | 2007-01-12 | 아스트라제네카 아베 | 화합물 |
| TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
| AU2005267706B2 (en) | 2004-08-02 | 2011-12-08 | University Of Virginia Patent Foundation | 2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity |
| WO2006023272A1 (en) | 2004-08-02 | 2006-03-02 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having a2a agonist activity |
| US7576069B2 (en) | 2004-08-02 | 2009-08-18 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
| GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| KR20070085371A (ko) | 2004-10-16 | 2007-08-27 | 아스트라제네카 아베 | 페녹시 벤즈아미드 화합물의 제조 방법 |
| GB0423044D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| EP1891069A1 (de) * | 2005-05-24 | 2008-02-27 | AstraZeneca AB | 2-phenylsubstituierte imidazol[4,5b]pyridin/pyrazin- und purinderivate als glucokinasemodulatoren |
| TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
| EP2027113A1 (de) * | 2005-07-09 | 2009-02-25 | AstraZeneca AB | Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes |
| JP2009500442A (ja) * | 2005-07-09 | 2009-01-08 | アストラゼネカ アクチボラグ | ２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物 |
| KR101346902B1 (ko) * | 2005-07-09 | 2014-01-02 | 아스트라제네카 아베 | 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체 |
| US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
| TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
| US8178509B2 (en) | 2006-02-10 | 2012-05-15 | University Of Virginia Patent Foundation | Method to treat sickle cell disease |
| US8188063B2 (en) | 2006-06-19 | 2012-05-29 | University Of Virginia Patent Foundation | Use of adenosine A2A modulators to treat spinal cord injury |
| TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| TW200825060A (en) * | 2006-10-26 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| KR20090090390A (ko) * | 2006-12-21 | 2009-08-25 | 아스트라제네카 아베 | Ｇｌｋ 활성제로서 유용한 신규 결정 화합물 |
| US8058259B2 (en) | 2007-12-20 | 2011-11-15 | University Of Virginia Patent Foundation | Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists |
| EP2324028A2 (de) | 2008-08-04 | 2011-05-25 | AstraZeneca AB | Therapeutische mittel 414 |
| GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
| GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
| WO2010116177A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity |
| AR076221A1 (es) * | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5251395A (en) * | 1975-10-21 | 1977-04-25 | Yamanouchi Pharmaceut Co Ltd | Preparation of novel pteridine derivaties |
| JPS5283800A (en) * | 1976-01-01 | 1977-07-12 | Yamanouchi Pharmaceut Co Ltd | Novel pteridine derivative |
| SE416810C (sv) * | 1977-10-14 | 1982-07-19 | Draco Ab | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
| US4452788A (en) * | 1982-04-21 | 1984-06-05 | Warner-Lambert Company | Substituted 8-phenylxanthines |
| FR2531085A1 (fr) * | 1982-07-28 | 1984-02-03 | Adir | Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant |
| GB8929208D0 (en) * | 1989-12-27 | 1990-02-28 | Almirall Lab | New xanthine derivatives |
| IT1240843B (it) * | 1990-05-24 | 1993-12-17 | Malesci Istituto Farmacobiologico | Derivati xantinici 1-7 sostituiti ad attivita' antiasmatica, loro sali fisiologicamente accettabili, loro composizioni farmaceutiche e procedimento per la loro preparazione. |
| NZ238609A (en) * | 1990-06-21 | 1993-12-23 | Schering Corp | Polycyclic guanine derivatives; preparation, pharmaceutical compositions, |
| GB9020921D0 (en) * | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
| JPH05194424A (ja) | 1991-10-09 | 1993-08-03 | Nikko Kyodo Co Ltd | 新規なピリミジン誘導体及び該誘導体を有効成分とする医薬 |
| JPH06135943A (ja) | 1992-09-14 | 1994-05-17 | Japan Energy Corp | 新規なウラシル誘導体及びそれを有効成分とするアレルギー疾患治療薬 |
-
1995
- 1995-06-05 US US08/463,277 patent/US5661153A/en not_active Expired - Fee Related
- 1995-07-17 NZ NZ272591A patent/NZ272591A/en unknown
- 1995-07-18 CA CA002154293A patent/CA2154293A1/en not_active Abandoned
- 1995-07-18 NO NO952854A patent/NO952854L/no unknown
- 1995-07-18 AU AU25057/95A patent/AU681034B2/en not_active Ceased
- 1995-07-18 EP EP95305047A patent/EP0700908A1/de not_active Withdrawn
- 1995-07-18 FI FI953479A patent/FI953479A7/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ272591A (en) | 1997-05-26 |
| NO952854D0 (no) | 1995-07-18 |
| FI953479A7 (fi) | 1996-01-20 |
| AU2505795A (en) | 1996-02-01 |
| AU681034B2 (en) | 1997-08-14 |
| FI953479A0 (fi) | 1995-07-18 |
| US5661153A (en) | 1997-08-26 |
| CA2154293A1 (en) | 1996-01-20 |
| EP0700908A1 (de) | 1996-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO952854L (no) | 1-arylpyrimidin-derivater | |
| FI931888A0 (fi) | Kramploesande cykliska fruktopyranossulfiter -och sulfater | |
| DK0696281T3 (da) | Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater | |
| NO985864L (no) | Nye anti-virale forbindelser | |
| DE50011034D1 (de) | N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| AU591860B2 (en) | Pyrolidineamide derivative having anti-prolyl endopeptidase | |
| CA2336412A1 (en) | Medicament for treatment of diabetes | |
| AU1400801A (en) | Aralkyl-1,2-diamines having calcimimetic activity and preparation mode | |
| RU95105435A (ru) | N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства | |
| NO971384D0 (no) | Pyrimidinylpyrazol-derivat | |
| CA2168937A1 (en) | Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines | |
| EP0557526B8 (de) | Pyrroloazepinverbindungen | |
| DE69116237D1 (de) | Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| ATE67199T1 (de) | Benzoxazin-derivate und verfahren zu ihrer herstellung. | |
| DK0913151T3 (da) | Anti-helicobacter Pylori-præparater indeholdende 1-methylcarbapenemderivater som den aktive bestanddel | |
| CA2092919A1 (en) | Epoxysuccinamic acid derivatives | |
| EA200500032A1 (ru) | Производные ацилоксипирролидина и их применение в качестве лигандов v1b или v1b и v1a рецепторов | |
| NO20003138L (no) | Ny anvendelse av lokalanestetika mot vaskulære hodepiner | |
| AU565778B2 (en) | 4-alkyl-2-hydroxy-3-methyl-2-phenyl-mor-pholine derivatives | |
| AU686104B2 (en) | Substituted amidinonaphthyl ester derivatives | |
| NO951650L (no) | Forebyggende middel mot blodplateaggregering | |
| AU686642B2 (en) | Cyclohexane derivatives | |
| SE9402596D0 (sv) | Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa | |
| MY101628A (en) | Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them. | |
| ATE220544T1 (de) | Neue verwendung von pyrazolopyridinverbindungen |